Relapsing Remitting Multiple Sclerosis News and Research

RSS
Elevated body temperature linked to fatigue in relapsing-remitting multiple sclerosis

Elevated body temperature linked to fatigue in relapsing-remitting multiple sclerosis

Scientists map key elements of immune overreaction triggered by influenza virus infection

Scientists map key elements of immune overreaction triggered by influenza virus infection

TSRI scientists describe severe immune overreaction caused by flu infections

TSRI scientists describe severe immune overreaction caused by flu infections

Study shows how immune system reconstitutes itself following immune-depleting therapy

Study shows how immune system reconstitutes itself following immune-depleting therapy

Active Biotech, Teva remain committed to NERVENTRA clinical development program for multiple sclerosis

Active Biotech, Teva remain committed to NERVENTRA clinical development program for multiple sclerosis

IQWiG study finds no added benefit of teriflunomide

IQWiG study finds no added benefit of teriflunomide

Health Canada approves Genzyme's Lemtrada for adults with relapsing remitting multiple sclerosis

Health Canada approves Genzyme's Lemtrada for adults with relapsing remitting multiple sclerosis

Takeda and Teva announce agreement related to commercialization of glatiramer acetate in Japan

Takeda and Teva announce agreement related to commercialization of glatiramer acetate in Japan

New data show positive results from Phase 4 study of Avonex Pen for treatment of RRMS patients

New data show positive results from Phase 4 study of Avonex Pen for treatment of RRMS patients

Revalesio to conduct RNS60 Phase IIa clinical trial in RRMS patients

Revalesio to conduct RNS60 Phase IIa clinical trial in RRMS patients

Biogen Idec Q3 total revenues increase 32% to $1.8 billion

Biogen Idec Q3 total revenues increase 32% to $1.8 billion

Study reveals gray matter atrophy in multiple sclerosis correlated with emotional decline

Study reveals gray matter atrophy in multiple sclerosis correlated with emotional decline

EMA's CHMP issues positive opinion for approval of Genzyme's LEMTRADA in Europe

EMA's CHMP issues positive opinion for approval of Genzyme's LEMTRADA in Europe

Study shows absence of gene leads to early onset of more serious disease in MS animal model

Study shows absence of gene leads to early onset of more serious disease in MS animal model

Study examines link between IL-17F and treatment response to interferon beta-1b in multiple sclerosis patients

Study examines link between IL-17F and treatment response to interferon beta-1b in multiple sclerosis patients

FDA accepts Teva Pharmaceutical's sNDA for COPAXONE

FDA accepts Teva Pharmaceutical's sNDA for COPAXONE

Natalizumab may be second-line option for pediatric MS patients

Natalizumab may be second-line option for pediatric MS patients

Positive top-line results from Biogen Idec’s peginterferon beta-1a Phase 3 trial on RRMS

Positive top-line results from Biogen Idec’s peginterferon beta-1a Phase 3 trial on RRMS

New nanoparticle halts relapsing remitting multiple sclerosis in mouse model

New nanoparticle halts relapsing remitting multiple sclerosis in mouse model

Caution over monoclonal antibody treatment for MS

Caution over monoclonal antibody treatment for MS